These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

130 related items for PubMed ID: 18403814

  • 1. Spermatogenesis in young adult patients with beta-thalassaemia major long-term treated with desferrioxamine.
    De Sanctis V, Borsari G, Brachi S, Govoni M, Carandina G.
    Georgian Med News; 2008 Mar; (156):74-7. PubMed ID: 18403814
    [Abstract] [Full Text] [Related]

  • 2. Spermatozoal DNA damage in patients with B thalassaemia syndromes.
    De Sanctis V, Perera D, Katz M, Fortini M, Gamberini MR.
    Pediatr Endocrinol Rev; 2008 Oct; 6 Suppl 1():185-9. PubMed ID: 19337176
    [Abstract] [Full Text] [Related]

  • 3. Acute effects of blood transfusion on pituitary gonadal axis and sperm parameters in adolescents and young men with thalassemia major: a pilot study.
    Soliman A, Yasin M, El-Awwa A, Osman M, de Sanctis V.
    Fertil Steril; 2012 Sep; 98(3):638-43. PubMed ID: 22749224
    [Abstract] [Full Text] [Related]

  • 4. Combined therapy of silymarin and desferrioxamine in patients with beta-thalassemia major: a randomized double-blind clinical trial.
    Gharagozloo M, Moayedi B, Zakerinia M, Hamidi M, Karimi M, Maracy M, Amirghofran Z.
    Fundam Clin Pharmacol; 2009 Jun; 23(3):359-65. PubMed ID: 19453758
    [Abstract] [Full Text] [Related]

  • 5. Zinc deficiency aggravates abnormal glucose metabolism in thalassemia major patients.
    Dehshal MH, Hooghooghi AH, Kebryaeezadeh A, Kheirabadi M, Kazemi S, Nasseh A, Shariftabrizi A, Pasalar P.
    Med Sci Monit; 2007 May; 13(5):CR235-9. PubMed ID: 17476196
    [Abstract] [Full Text] [Related]

  • 6. Serum ferritin level as a predictor of impaired growth and puberty in thalassemia major patients.
    Shalitin S, Carmi D, Weintrob N, Phillip M, Miskin H, Kornreich L, Zilber R, Yaniv I, Tamary H.
    Eur J Haematol; 2005 Feb; 74(2):93-100. PubMed ID: 15654898
    [Abstract] [Full Text] [Related]

  • 7. Abnormal seminal parameters in patients with thalassemia intermedia and low serum folate levels.
    De Sanctis V, Candini G, Giovannini M, Raiola G, Katz M.
    Pediatr Endocrinol Rev; 2011 Mar; 8 Suppl 2():310-3. PubMed ID: 21705984
    [Abstract] [Full Text] [Related]

  • 8. Intensification of chelating-therapy in patients with thalassemia major.
    Laws HJ, Göbel U, Christaras A, Janssen G.
    Klin Padiatr; 2005 Mar; 217(3):120-5. PubMed ID: 15858702
    [Abstract] [Full Text] [Related]

  • 9. [Evaluation of the efficacy of chelation therapy with deferoxamine in patients with thalassemia major].
    Rodríguez Galindo C, Ortega Aramburu JJ, Alonso JL, Albisu M, Casaldáliga J, Díaz de Heredia C, Olivé T, Bastida P.
    Med Clin (Barc); 1994 May 21; 102(19):721-4. PubMed ID: 8041200
    [Abstract] [Full Text] [Related]

  • 10. Relationship of serum and seminal plasma zinc levels and serum testosterone in oligospermic and azoospermic infertile men.
    Ali H, Baig M, Rana MF, Ali M, Qasim R, Khem AK.
    J Coll Physicians Surg Pak; 2005 Nov 21; 15(11):671-3. PubMed ID: 16300697
    [Abstract] [Full Text] [Related]

  • 11. Chelation therapy with desferrioxamine does not normalize ferritin level but attenuates oxidative damage and improves total antioxidant level in Malaysian Chinese beta-thalassaemia major patients.
    Kuppusamy UR, Tan JA.
    West Indian Med J; 2011 Jan 21; 60(1):3-8. PubMed ID: 21809703
    [Abstract] [Full Text] [Related]

  • 12. Varicocele sclerotherapy improves serum inhibin B levels and seminal parameters.
    Di Bisceglie C, Bertagna A, Baldi M, Lanfranco F, Tagliabue M, Gazzera C, Gandini G, Manieri C.
    Int J Androl; 2007 Dec 21; 30(6):531-6. PubMed ID: 17376219
    [Abstract] [Full Text] [Related]

  • 13. Intensive long-term intravenous iron-chelation therapy with deferoxamine in thalassemic patients.
    Cianciulli P, Forte L, Sorrentino F, Palombi M, Papa G, Marciani MG.
    Bone Marrow Transplant; 1993 Dec 21; 12 Suppl 1():5-8. PubMed ID: 8374563
    [No Abstract] [Full Text] [Related]

  • 14. Hypogonadism, diabetes mellitus, hypothyroidism, hypoparathyroidism: incidence and prevalence related to iron overload and chelation therapy in patients with thalassaemia major followed from 1980 to 2007 in the Ferrara Centre.
    Gamberini MR, De Sanctis V, Gilli G.
    Pediatr Endocrinol Rev; 2008 Oct 21; 6 Suppl 1():158-69. PubMed ID: 19337172
    [Abstract] [Full Text] [Related]

  • 15. Early iron reduction programme for thalassaemia patients after bone marrow transplantation.
    Li CK, Lai DH, Shing MM, Chik KW, Lee V, Yuen PM.
    Bone Marrow Transplant; 2000 Mar 21; 25(6):653-6. PubMed ID: 10734300
    [Abstract] [Full Text] [Related]

  • 16. Cardiac disease in beta-thalassaemia major: Is it reversible?
    Atiq M, Bana M, Ahmed US, Bano S, Yousuf M, Fadoo Z, Khurshid M.
    Singapore Med J; 2006 Aug 21; 47(8):693-6. PubMed ID: 16865210
    [Abstract] [Full Text] [Related]

  • 17. Epididymal and sex accessory gland secretions in transfusion-dependent beta-thalassemic patients: evidence of an impaired prostatic function.
    Carpino A, De Sanctis V, Siciliano L, Maggiolini M, Vivacqua A, Pinamonti A, Sisci D, Andó S.
    Exp Clin Endocrinol Diabetes; 1997 Aug 21; 105(3):169-74. PubMed ID: 9228514
    [Abstract] [Full Text] [Related]

  • 18. Long term audiological evaluation of beta-thalassemic patients.
    Kontzoglou G, Koussi A, Economou M, Tsatra I, Perifanis V, Noussios G, Athanassiou-Metaxa M.
    Acta Otorhinolaryngol Belg; 2004 Aug 21; 58(2):113-7. PubMed ID: 15515654
    [Abstract] [Full Text] [Related]

  • 19. Insulin sensitivity assessment with euglycemic insulin clamp in adult beta-thalassaemia major patients.
    Tsapas A, Vlachaki E, Christoforidis A, Sarigianni M, Bekiari E, Perifanis V, Tsapas V, Paletas K, Athanassiou-Metaxa M.
    Eur J Haematol; 2007 Dec 21; 79(6):526-30. PubMed ID: 17961176
    [Abstract] [Full Text] [Related]

  • 20. Sensory neural hearing loss in beta-thalassemia major patients treated with deferoxamine.
    Shamsian BS, Aminasnafi A, Moghadassian H, Gachkar L, Arzanian MT, Alavi S, Esfehani H, Garallahi F, Amini R.
    Pediatr Hematol Oncol; 2008 Sep 21; 25(6):502-8. PubMed ID: 18728969
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.